WBI Investments’s DexCom DXCM Stock Holding History

WBI Investments’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-8,810	Closed	-$553K	–	315
2026 Q1	$553K	Buy	+8,810	New	+$614K	0.15%	175
2024 Q2	–	Sell	-2,177	Closed	-$302K	–	183
2024 Q1	$302K	Buy	+2,177	New	+$274K	0.06%	170

Other funds holding DXCM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

WBI Investments's DXCM Position: Q2 2026 in Review

WBI Investments sold out of DexCom (DXCM) in Q2 2026, closing a stake of 8,810 shares — an estimated $553K sold.

WBI Investments first reported a position in DXCM in Q1 2024 and held it in 2 quarters. The position peaked at $553K in Q1 2026. 974 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

WBI Investments reported no remaining DexCom position as of Q2 2026 after selling out during the quarter.
WBI Investments sold 8,810 DexCom shares in Q2 2026, an estimated $553K.
WBI Investments first reported a position in DexCom in Q1 2024 and held it in 2 quarters.
WBI Investments's DexCom position peaked at $553K in Q1 2026.
974 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on WBI Investments's 13F filing for Q2 2026, filed 11 Aug 2026.